How to Use Vector Assets

FDA’s Second Platform Designation Goes to Krystal After Sarepta Withdrawal

After the FDA revoked Sarepta Therapeutics’ platform designation in July, Krystal Biotech is “poised to be the first major ...

Results that may be inaccessible to you are currently showing.